Cite
MLA Citation
Michael Lübbert et al.. “Elevated fetal haemoglobin is a predictor of better outcome in MDS/AML patients receiving 5‐aza‐2′‐deoxycytidine (Decitabine).” British journal of haematology, vol. 176, 2017, pp. 609–617. http://access.bl.uk/ark:/81055/vdc_100041767516.0x00003b